Latest debt-to-equity ratio
Context Therapeutics Debt-to-equity ratio
Direct answer
Context Therapeutics's debt-to-equity ratio is 0.64%.
The verified market snapshot reports 0.64%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.64%
Explore related company data
View Context Therapeutics's market capitalizationView Context Therapeutics's price-to-book ratioView Context Therapeutics's return on equityView Context Therapeutics's 52-week price rangeView Context Therapeutics's profit marginView all Context Therapeutics key metricsReturn to Context Therapeutics profile